SANTA CLARA, Calif., June 6, 2024 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in growing and advertising expertise services to healthcare suppliers to fight persistent illnesses, at present introduced that it has bought a further 247 bitcoins for an mixture $17 million in money, inclusive of charges and bills.
As of June 6, 2024, Semler holds a complete of 828 bitcoins, which had been acquired for an mixture $57 million, inclusive of charges and bills.
“Semler remains focused on our two strategies of expanding our healthcare business and acquiring and holding bitcoin,” stated Doug Murphy-Chutorian, MD, Semler Scientific’s chief government officer. “The company now holds 828 bitcoins, underscoring our view that bitcoin is a compelling investment and can serve as a reliable store of value. We will continue to pursue our strategy of purchasing bitcoins with cash.”
About Semler Scientific, Inc:
Semler Scientific, Inc. develops, manufactures and markets revolutionary services to fight persistent illnesses. Its flagship product, QuantaFlo®, which is patented and cleared by the U.S. Meals and Drug Administration (FDA), is a speedy point-of-care check that measures arterial blood move within the extremities. The QuantaFlo check aids within the prognosis of cardiovascular illnesses, resembling peripheral arterial illness (PAD), and Semler Scientific is searching for a brand new 510(ok) clearance for expanded indications. QuantaFlo is utilized by healthcare suppliers to judge their affected person’s threat of mortality and main hostile cardiovascular occasions (MACE). Semler Scientific additionally invests in bitcoin and has adopted bitcoin as its main treasury reserve asset. Further details about Semler Scientific will be discovered at www.semlerscientific.com.
Ahead-Wanting Statements
This press release comprises “forward-looking” statements. Such statements will be recognized by, amongst different issues, using forward-looking language such because the phrases “believe,” “goal,” “may,” “will,” “intend,” “expect,” “anticipate,” “estimate,” “project,” “would,” “could” or phrases with related which means or the negatives of those phrases or by the dialogue of technique or intentions. The forward-looking statements on this launch embody categorical or implied statements relating to the brand new bitcoin technique, the acquisition of extra bitcoin with money, and the enlargement of its healthcare enterprise, amongst others. Such forward-looking statements are topic to quite a few dangers and uncertainties that would trigger Semler Scientific’s precise outcomes to vary materially from these mentioned right here, resembling dangers inherent with investing in bitcoin, together with bitcoin‘s volatility; threat of implementing a brand new treasury technique; threat that insurance policy and different prospects is not going to proceed to license its cardiovascular testing merchandise; threat of modifications within the reimbursement panorama for its prospects together with associated to the CMS charge announcement; threat of acquiring a brand new 510(ok) clearance for expanded indications; together with these different threat components detailed in Semler Scientific’s filings with the Securities and Change Fee. These forward-looking statements contain assumptions, estimates, and uncertainties that replicate present inner projections, expectations or beliefs. There will be no assurance that such statements will show to be correct, and precise outcomes and future occasions may differ materially from these anticipated in such statements. All forward-looking statements contained on this press release are certified of their entirety by these cautionary statements and the danger components described above. Moreover, all such statements are made as of the date of this launch and Semler Scientific assumes no obligation to replace or revise these statements until in any other case required by regulation.
INVESTOR CONTACT:
Renae Cormier
Chief Monetary Officer
[email protected]
SOURCE Semler Scientific, Inc.